deltatrials
Completed OBSERVATIONAL NCT05074875

COVID-19 Respiratory Outcomes Registry

Post COVID-19 Hypoxemic Respiratory Failure Residual Pathophysiologic Outcomes

Sponsor: Boehringer Ingelheim

Conditions Covid19
Updated 8 times since 2021 Last updated: Jul 25, 2023 Started: Jan 15, 2021 Primary completion: May 9, 2023 Completion: May 9, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Covid19 and is currently completed. Boehringer Ingelheim leads this study, which shows 8 recorded versions since 2021 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Nov 2021 – ~Dec 2021 · 30 days · monthly snapshotRecruiting~Dec 2021 – ~Nov 2022 · 11 months · monthly snapshotRecruiting~Nov 2022 – ~Mar 2023 · 4 months · monthly snapshotActive Not Recruiting~Mar 2023 – ~Aug 2023 · 5 months · monthly snapshotActive Not Recruiting~Aug 2023 – ~Jul 2024 · 11 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

8 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Aug 2023 — Jul 2024 [monthly]

    Completed

    Status: Active Not RecruitingCompleted

  5. Mar 2023 — Aug 2023 [monthly]

    Active Not Recruiting

Show 3 earlier versions
  1. Nov 2022 — Mar 2023 [monthly]

    Active Not Recruiting

    Status: RecruitingActive Not Recruiting

  2. Dec 2021 — Nov 2022 [monthly]

    Recruiting

  3. Nov 2021 — Dec 2021 [monthly]

    Recruiting

    First recorded

Jan 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Boehringer Ingelheim
  • Weill Medical College of Cornell University
Data source: Weill Medical College of Cornell University

For direct contact, visit the study record on ClinicalTrials.gov .